| HIV Infection |
1 |
1 |
| AIDS |
0 |
0.49 |
| Drug Interaction |
0 |
0.33 |
| Outpatient Clinic |
0 |
0.33 |
| Pandemic |
0 |
0.33 |
| Cancer |
0 |
0.16 |
| CAR-T |
0 |
0.16 |
| COVID-19 |
0 |
0.16 |
| Epidemic |
0 |
0.16 |
| Food and Drug Administration (FDA) |
0 |
0.16 |
| Hand |
0 |
0.16 |
| Health Care Quality, Access, and Evaluation |
0 |
0.75 |
| Heart |
0 |
0.16 |
| Hepatitis |
0 |
0.16 |
| Hepatitis A |
0 |
0.16 |
| Immunotherapy |
0 |
0.16 |
| Medical Innovations |
0 |
0.16 |
| New York |
0 |
0.16 |
| Private Practice |
0 |
0.16 |
| Prophylaxis |
0 |
0.16 |
| Sexually Transmitted Infection (STI) |
0 |
0.16 |
| Weight Gain |
0 |
0.16 |
| Social Determinants of Health |
0 |
0.14 |
| Biologic Therapy |
0 |
0.12 |
| Health Care Reform |
0 |
0.12 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.05 |
| Revenue and Practice Management |
0 |
0.05 |
| Weight Management |
0 |
0.05 |